MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/23993693251413641

Медицинская библиотека · Journal of onco-nephrology · 2026

Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States.

Boppana Samhita, Blosser Christopher D, Webber Allison B, Gupta Gaurav, Singh Neeraj, Master Samip, Parasuraman Raviprasenna, Campagnaro Erica L, Java Anuja, Sprangers Ben, Bhasin-Chhabra Bhavna, Lum Erik L, Khirfan Diala, Alexander Mariam, Leung Nelson, Landau Heather, Murakami Naoka

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Plasma cell dyscrasia (PCD) is a rare but important cause of end stage kidney disease (ESKD). Kidney transplant is the treatment of choice in patients with ESKD. However, the complexity of PCD care and risk of disease recurrence poses challenges to kidney transplant candidacy and outcomes. We examined the current clinical practice patterns of clinicians who care for patients with PCD and identified barriers to kidney transplantation for patients with PCD.

METHODS

A web-based survey was developed and distributed from January to July 2024 to kidney transplant clinicians (American Society of Transplant (AST) members), hematologists (PCD experts), and onco-nephrologists.

RESULTS

Seventy clinicians (50 transplant nephrologists, 18 hematologists, and two surgeons) from 42 transplant centers in the US participated in the survey. Clinical practice patterns pre and post kidney transplant for patients with PCD are highly variable among institutions, and only 36% reported having a protocol for pre- and post-transplant management for patients with PCD. Particularly, the requirement for pre-transplant hematologic remission criteria, induction and maintenance immunosuppression regimens and protocols for prophylaxis and screening for opportunistic infection are areas of future study. Clinicians listed lack of data and practice guidance as well as communication challenges among multiple specialties especially hematology and kidney transplant clinicians as notable barriers.

CONCLUSIONS

Our study identified the highly variable current practice patterns when evaluating and managing patients with PCD for kidney transplant. Our findings emphasize the need for collecting and sharing clinical data to support standardized practices and serve as a basis for the upcoming multi-societal management recommendation for kidney transplant for patients with PCD.

Для цитирования: Boppana Samhita, Blosser Christopher D, Webber Allison B, Gupta Gaurav, Singh Neeraj, Master Samip, Parasuraman Raviprasenna, Campagnaro Erica L, Java Anuja, Sprangers Ben, Bhasin-Chhabra Bhavna, Lum Erik L, Khirfan Diala, Alexander Mariam, Leung Nelson, Landau Heather, Murakami Naoka. Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States.. Journal of onco-nephrology. 2026. DOI: 10.1177/23993693251413641.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.